Supplementary Protection Certificate Search

Details

SPC number
SPC/GB07/046
Filing date
13 August 2007

Applicant(s) details

Name
Merck Sharp & Dohme Corp.
Address
126 East Lincoln Avenue
Rahway
New Jersey
NJ 07065-0900
USA

Agent details

Name
Merck Sharp & Dohme Corp.
Address
120 Moorgate
London
EC2M 6UR


Patent details

Patent number
EP1412357
Title
Beta- amino tetrahydroimidazo(1,2- A)pyrazines and tetrahydrotriazolo(4,3- A)pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes

UK authorisation details

Authority date
23 March 2007
UK authorisations
  • EU/1/07/383/001
  • EU/1/07/383/002
  • EU/1/07/383/003
  • EU/1/07/383/004
  • EU/1/07/383/005
  • EU/1/07/383/006
  • EU/1/07/383/007
  • EU/1/07/383/008
  • EU/1/07/383/009
  • EU/1/07/383/010
  • EU/1/07/383/011
  • EU/1/07/383/012
  • EU/1/07/383/013
  • EU/1/07/383/014
  • EU/1/07/383/015
  • EU/1/07/383/016
  • EU/1/07/383/017
  • EU/1/07/383/018

Product details

Product description
Sitagliptin phosphate monohydrate
Status
Granted - 19 May 2008
Product type
Medicinal

Life details

In force date
Actual expiry date
Maximum expiry date
22 March 2022
Invalid date
Lapsed date
Lapsed status

Extension details

Lodged date
13 March 2020
Granted date
21 July 2020
Refused date
Revoked date
Expiry date
22 September 2022
Authorisation number
EU/1/07/383/001-024
Authorisation date
21 March 2007
Information concerning revocation actions and other legal proceedings on an SPC is included in the Patents Status Information record of the relevant patent.